A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/165 (2006.01)
Patent
CA 2624018
The present invention is directed to methods for providing long-term treatment of fibromyalgia syndrome (FMS) by administering a dual re-uptake inhibitor to a patient with FMS. More particularly, the present invention is directed to the long-term treatment of FMS by administering a norepinephrine-serotonin reuptake inhibitor (NSRI) to a patient with FMS.
L'invention concerne des méthodes de traitement à long terme du syndrome de la fibromyalgie par l'administration, à un patient atteint dudit syndrome, d'un double inhibiteur de recapture. L'invention concerne plus particulièrement un traitement à long terme du syndrome de la fibromyalgie par l'administration, à un patient atteint dudit syndrome, d'un double inhibiteur de recapture de la norépinéphrine et de la sérotonine.
Gendreau Michael
Kranzler Jay D.
Rao Srinivas G.
Cypress Bioscience Inc.
Robic
LandOfFree
Milnacipran for the long-term treatment of fibromyalgia... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Milnacipran for the long-term treatment of fibromyalgia..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Milnacipran for the long-term treatment of fibromyalgia... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1906689